| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.09 | 0.1 |